FDA Inspection
Regeneron Pharmaceuticals IncFDA Inspection 1155063 - Regeneron Pharmaceuticals Inc - October 25, 2021
Discuss this record with AI
Record Details
This FDA Inspection record concerns Regeneron Pharmaceuticals Inc, with an inspection on October 25, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · f2f814f1-cd34-4b8c-9b74-fb3e6156fa2d
Violation Codes4
21 CFR 211.113(b)21 CFR 211.19221 CFR 211.42(c)(10)(v)21 CFR 600.14(c)
Full citation text and observation details available on the Dashboard.